November 5, 2015

New Pancreatic Cancer Clinical Trial Uses Aggressive Treatment


Physician and scientist Gregory Gan, MD, PhD, is the principal investigator for a new clinical trial that may help more people to undergo surgery to remove their pancreas tumors. And that may help more of them to live longer.

The new clinical trial uses an aggressive treatment approach. “This clinical trial utilizes some of the best aspects of what we’ve learned so far with chemotherapy and radiation,” says Gregory Gan, MD, PhD. “It combines these with a new and exciting therapy called immunotherapy — a treatment which harnesses the body's immune system to help with fighting cancer.” Gan specializes in radiation oncology at UNM Comprehensive Cancer Center.

Dr. Gan spoke to Eddie Garcia on KOB TV4, to Mike Jaxson, KSVP-FM, and to Angela Brauer, KOAT-TV, about the new pancreatic cancer clinical trial. Also read the article in The Mountain View Telegraph and read the full press release.

Dr. Gan's interview with Mike Jaxson, KSVP-FM about the new clinical trial:

Tags: clinical research, clinical trial, In the News Archive, pancreas cancer, pancreatic, Pancreatic Cancer, unmccc